placeholder image
T. Danne All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 
    Endocrine Reviews. 2023
  • Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: the head-to-head randomized controlled InRange trial. 
    Diabetes, Obesity & Metabolism. 2023
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 
    Lancet (London, England). 2021
  • Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. 
    Diabetes Technology & Therapeutics. 2021
  • The digital/virtual diabetes clinic: the future Is now-recommendations from an international panel on diabetes digital technologies introduction. 
    Diabetes Technology & Therapeutics. 2021
  • InRange: comparison of the second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in persons with type 1 diabetes using continuous glucose monitoring-study design. 
    Diabetes Therapy. 2020
    • Conference Poster
  • CGM-based clinical targets: recommendations from the International Consensus on Time-in-Range (TIR) [poster]
    2019
    • Review
  • Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 
    The lancet. Diabetes & endocrinology. 2023
  • Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 
    Diabetes care. 2019
  • International consensus on use of continuous glucose monitoring [review]. 
    Diabetes care. 2017
    • Contact
    full name
  • T. Danne
    • Quick Info
     
    Collaboration